摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氨甲基苯硼酸频哪醇酯盐酸盐 | 138500-88-6

中文名称
4-氨甲基苯硼酸频哪醇酯盐酸盐
中文别名
4(4-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)苯基)甲胺盐酸盐;4-(氨甲基)苯硼酸频哪醇酯;4-氨基甲基OHENYL硼酸嚬哪醇酯
英文名称
(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
英文别名
4-aminomethylphenylboronic acid pinacol ester;[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine
4-氨甲基苯硼酸频哪醇酯盐酸盐化学式
CAS
138500-88-6
化学式
C13H20BNO2
mdl
MFCD06213229
分子量
233.118
InChiKey
FPUVAGQUKWMDKN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    342.6±25.0 °C(Predicted)
  • 密度:
    1.03±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.02
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.538
  • 拓扑面积:
    44.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2931900090
  • 安全说明:
    S26,S36/37/39
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    应存放在2-8°C的环境中,避免光照,并需保存在惰性气体中。

SDS

SDS:bb9c372a35cdd8a098e1b922ef35dfc1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Aminomethylphenylboronic acid, pinacol ester
Synonyms: (4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Aminomethylphenylboronic acid, pinacol ester
CAS number: 138500-88-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C13H20BNO2
Molecular weight: 233.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [18F]-radiolabeling and PET study in rats
    作者:Aziz Ouach、Johnny Vercouillie、Emilie Bertrand、Nuno Rodrigues、Frederic Pin、Sophie Serriere、Liliana Boiaryna、Agnes Chartier、Nathalie Percina、Pakorn Tangpong、Zuhal Gulhan、Celine Mothes、Jean-Bernard Deloye、Denis Guilloteau、Guylene Page、Franck Suzenet、Frederic Buron、Sylvie Chalon、Sylvain Routier
    DOI:10.1016/j.ejmech.2019.06.049
    日期:2019.10
    and nine of them exhibited Ki values below nanomolar concentrations. The best scores were always obtained when the 5-phenyl-2-thiophenyl core was attached to the triazole. The selectivity of these compounds towards the nicotinic α4β2 and serotoninergic 5HT3 receptors was assessed and their brain penetration was quantified by the preparation and in vivo evaluation of two [18F] radiolabelled derivatives
    在本文中,我们描述了使用有效的三步序列(包括与市售的硼衍生物和自制的硼衍生物的Suzuki-Miyaura交叉偶联反应)设计和合成双(Het)芳基-1,2,3-三唑喹核苷α7R配体的方法。 。SAR的勘探需要制备罕见的硼衍生物。测试了40种最终药物结合靶标的能力,其中9种药物的Ki值低于纳摩尔浓度。当将5-苯基-2-硫代苯基核心连接到三唑上时,总会获得最高分。通过制备和体内评估两种化合物,评估了这些化合物对烟碱型α4β2和5羟色胺能5HT3受体的选择性,并定量了它们的脑渗透率[ 18F]放射性标记的衍生物。从我们的结果可以预期,这些化合物中的一些将适合进一步发展,并将对认知障碍产生影响。
  • General and selective synthesis of primary amines using Ni-based homogeneous catalysts
    作者:Kathiravan Murugesan、Zhihong Wei、Vishwas G. Chandrashekhar、Haijun Jiao、Matthias Beller、Rajenahally V. Jagadeesh
    DOI:10.1039/d0sc01084g
    日期:——
    Ni-triphos complex as the first Ni-based homogeneous catalyst for both reductive amination of carbonyl compounds with ammonia and hydrogenation of nitroarenes to prepare all kinds of primary amines. Remarkably, this Ni-complex enabled the synthesis of functionalized and structurally diverse benzylic, heterocyclic and aliphatic linear and branched primary amines as well as aromatic primary amines starting
    通过应用丰富且原子经济的试剂来开发用于工业上相关的胺化和氢化反应的贱金属催化剂,对于经济高效且可持续地合成代表非常重要的化学物质的胺而言,仍然至关重要。尤其是,伯胺的合成至关重要,因为这些化合物用作生产增值精细化学品和散装化学品以及药品,农用化学品和原料的关键前体和主要中间体。在这里,我们报道了一种Ni-triphos络合物,它是第一个用于镍的羰基化合物与氨的还原胺化和硝基芳烃加氢制备各种伯胺的Ni基均相催化剂。值得注意的是,这种镍配合物可以合成功能化且结构多样的苄基,杂环和脂肪族直链和支链伯胺以及芳香族伯胺,是使用氨和分子氢从廉价且易于获得的羰基化合物(醛和酮)和硝基芳烃开始的。这种镍催化的还原胺化方法已用于胺化更复杂的药物和类固醇衍生物。已经对基于Ni-triphos的还原胺化反应进行了详细的DFT计算,结果表明整个反应具有H的内球机理。这种镍催化的还原胺化方法已用于胺化更复杂的药物和
  • The Synthesis of Primary Amines through Reductive Amination Employing an Iron Catalyst
    作者:Christoph Bäumler、Christof Bauer、Rhett Kempe
    DOI:10.1002/cssc.202000856
    日期:2020.6.19
    The reductive amination of ketones and aldehydes by ammonia is a highly attractive method for the synthesis of primary amines. The use of catalysts, especially reusable catalysts, based on earth‐abundant metals is similarly appealing. Here, the iron‐catalyzed synthesis of primary amines through reductive amination was realized. A broad scope and a very good tolerance of functional groups were observed
    氨将酮和醛还原胺化是合成伯胺的极具吸引力的方法。同样,使用基于富含地球的金属的催化剂,尤其是可重复使用的催化剂也具有吸引力。在此,通过还原胺化实现了铁催化的伯胺合成。观察到广泛的范围和对官能团的很好的耐受性。酮,包括纯脂肪族的酮,芳基-烷基,二烷基和杂环,以及醛,可以平稳地转化为其相应的伯胺。此外,还演示了胺化药物,生物活性化合物和天然产物。可以容忍许多官能团,例如羟基,甲氧基,二恶唑,磺酰基和硼酸酯取代基。催化剂易于操作,选择性,可重复利用,氨水可作为氮源。关键是使用特定的Fe络合物进行催化剂合成,并使用N掺杂SiC材料作为催化剂载体。
  • [EN] PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS<br/>[FR] PURINONES UTILISÉS COMME INHIBITEURS DE LA PROTÉASE SPÉCIFIQUE DE L'UBIQUITINE 1
    申请人:FORMA THERAPEUTICS INC
    公开号:WO2017087837A1
    公开(公告)日:2017-05-26
    The application relates to inhibitors of USP1 useful in the treatment of cancers, and other USP1 associated diseases and disorders, having the Formula: (I), where R1, R2, R3, R3', R4, R5, X1, X2, X3, X4, and n are described herein.
    该应用涉及对USP1的抑制剂,用于治疗癌症和其他与USP1相关的疾病和紊乱,其化学式为:(I),其中R1、R2、R3、R3'、R4、R5、X1、X2、X3、X4和n如本文所述。
  • Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors
    作者:Shujing Xu、Shu Song、Lin Sun、Ping Gao、Shenghua Gao、Yue Ma、Dongwei Kang、Yusen Cheng、Xujie Zhang、Srinivasulu Cherukupalli、Erik De Clercq、Christophe Pannecouque、Xinyong Liu、Peng Zhan
    DOI:10.1016/j.bmc.2021.116531
    日期:2022.1
    around the entrance channel of the HIV-1 reverse transcriptase (RT) binding pocket, we innovatively designed and synthesized a series of novel indolylarylsulfones (IASs) bearing phenylboronic acid and phenylboronate ester functionalities at the indole-2-carboxamide as new HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) through structure-based drug design. All the newly synthesized compounds
    为了探索 HIV-1 逆转录酶 (RT) 结合口袋入口通道周围的化学空间,我们创新性地设计并合成了一系列在 indole-2-carboxamide 上具有苯基硼酸和苯基硼酸酯官能团的新型吲哚芳基砜 (IAS)通过基于结构的药物设计新的 HIV-1 非核苷类逆转录酶抑制剂 (NNRTIs)。所有新合成的化合物都表现出对野生型 (WT) HIV-1 的优异至中等效力,EC 50值范围为 6.7 至 42.6 nM。其中,(3-乙基苯基)硼酸取代的吲哚-2-甲酰胺和(4-乙基苯基)硼酸酯取代的吲哚-2-甲酰胺被发现是最有效的抑制剂(EC 50  = 8.5 nM, SI = 3310; EC 50 = 6.7 nM,SI = 3549,分别)。值得注意的是,(3-乙基苯基)硼酸取代的吲哚-2-甲酰胺对单个 HIV-1 突变体 L100I (EC 50  = 7.3 nM)、K103N (EC 50
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐